Component: (Network and Table) | |
---|---|
Network |
00000006 - Statement - Statements of Cash Flows—Indirect Method
(http://ultra.com.br/role/StatementsOfCashFlowsindirectMethod) |
Table | (Implied) |
Reporting Entity [Axis] | 0001094972 (http://www.sec.gov/CIK) |
Statement of cash flows [abstract] | Period [Axis] | ||
---|---|---|---|
2017-01-01 - 2017-12-31 |
2016-01-01 - 2016-12-31 |
2015-01-01 - 2015-12-31 | |
Statement of cash flows [abstract] |
|
|
|
Cash flows from operating activities |
|
|
|
Net income for the year |
1,573,868,000 |
1,570,618,000 |
1,512,972,000 |
Adjustments to reconcile net income to cash provided by operating activities |
|
|
|
Share of loss (profit) of joint ventures and associates |
( |
( |
|
Depreciation and amortization |
|
|
|
PIS and COFINS credits on depreciation |
|
|
|
Asset retirement obligation |
( |
( |
( |
Interest, monetary, and foreign exchange rate variations |
|
|
|
Deferred income and social contribution taxes |
( |
( |
|
(Gain) loss on disposal of property, plant and equipment and intangibles |
|
|
( |
Others |
( |
( |
|
Adjustments, total |
|
|
|
(Increase) decrease in current assets |
|
|
|
Trade receivables |
( |
( |
( |
Inventories |
( |
( |
( |
Recoverable taxes |
( |
|
( |
Dividends received from joint-ventures and associates |
|
|
|
Insurance and other receivables |
|
( |
|
Prepaid expenses |
( |
( |
( |
Increase (decrease) in current liabilities |
|
|
|
Trade payables |
|
|
|
Salaries and related charges |
|
( |
|
Taxes payable |
|
|
|
Income and social contribution taxes |
|
|
|
Post-employment benefits |
|
|
|
Provision for tax, civil, and labor risks |
|
|
( |
Insurance and other payables |
( |
|
|
Deferred revenue |
( |
( |
|
(Increase) decrease in non-current assets |
|
|
|
Trade receivables |
( |
( |
( |
Recoverable taxes |
( |
( |
( |
Escrow deposits |
( |
( |
( |
Other receivables |
( |
|
( |
Prepaid expenses |
( |
( |
( |
Increase (decrease) in non-current liabilities |
|
|
|
Post-employment benefits |
|
( |
|
Provision for tax, civil, and labor risks |
( |
|
|
Other payables |
|
( |
|
Deferred revenue |
|
|
|
Income and social contribution taxes paid |
( |
( |
( |
Net cash provided by operating activities |
|
|
|
Cash flows from investing activities |
|
|
|
Financial investments, net of redemptions |
|
( |
|
Acquisition of subsidiary, net of cash acquired |
|
|
|
Acquisition of property, plant, and equipment |
( |
( |
( |
Acquisition of intangible assets |
( |
( |
( |
Capital increase in joint ventures |
( |
( |
( |
Proceeds from disposal of property, plant and equipment and intangibles |
|
|
|
Net cash used in investing activities |
(
|
(
|
(
|
Cash flows from financing activities |
|
|
|
Loans and debentures |
|||
Proceeds |
|
|
|
Repayments |
( |
( |
( |
Interest paid |
( |
( |
( |
Payments of financial lease |
( |
( |
( |
Dividends paid |
( |
( |
( |
Acquisition of non-controlling interests of subsidiaries |
|
|
( |
Acquisition of own shares to be held in treasury |
|
|
( |
Related parties |
|
( |
|
Net cash provided by (used in) financing activities |
|
|
(
|
Effect of exchange rate changes on cash and cash equivalents in foreign currency |
|
( |
( |
Increase (decrease) in cash and cash equivalents
|
|
|
( |
Cash and cash equivalents at the beginning of the year |
4,274,158,000 |
|
|
Cash and cash equivalents at the end of the year |
5,002,004,000
|
4,274,158,000
|
2,702,893,000
|
Additional information—transactions that do not affect cash and cash equivalents: |
|
|
|
Extrafarma acquisition – capital increase and subscription warrants |
|||
Extrafarma acquisition – gross debt assumed on the closing date |